CELC logo

CELC
Celcuity Inc

1,991
Mkt Cap
$6.38B
Volume
1.42M
52W High
$151.02
52W Low
$10.60
PE Ratio
-34.09
CELC Fundamentals
Price
$132.88
Prev Close
$130.91
Open
$131.09
50D MA
$123.48
Beta
1.06
Avg. Volume
754,558.87
EPS (Annual)
-$3.79
P/B
120.03
Rev/Employee
$0.00
$4,544.02
Loading...
Loading...
News
all
press releases
Celcuity's Cancer Drug Expansion Could Ignite Massive New Market Opportunity: Analyst
Celcuity expands VIKTORIA-2 to endocrine-sensitive breast cancer patients and advances injectable gedatolisib formulation.read more...
Benzinga
News Placeholder
More News
News Placeholder
Celcuity (CELC) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
Celcuity (CELC) to Release Earnings on Wednesday
Celcuity (NASDAQ:CELC) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 13. (View Earnings Report at...
MarketBeat
News Placeholder
Celcuity, Inc. (NASDAQ:CELC) Given Consensus Rating of "Moderate Buy" by Analysts
Celcuity, Inc. (NASDAQ:CELC - Get Free Report) has earned an average recommendation of "Moderate Buy" from the twelve ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have issu...
MarketBeat
News Placeholder
Best Biotech Stocks To Research - May 4th
Celcuity, Danaher, Vertex Pharmaceuticals, Rallybio, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies focused on developing biological products, drugs, diagnostics, or platform technologies...
MarketBeat
News Placeholder
Citizens Jmp Increases Celcuity (NASDAQ:CELC) Price Target to $160.00
Citizens Jmp increased their price target on shares of Celcuity from $150.00 to $160.00 and gave the stock a "market outperform" rating in a report on Monday...
MarketBeat
News Placeholder
Celcuity (NASDAQ:CELC) Reaches New 12-Month High on Analyst Upgrade
Celcuity (NASDAQ:CELC) Hits New 52-Week High on Analyst Upgrade...
MarketBeat
News Placeholder
"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension
"Just Another Dip Investors Will Buy": Futures Drop, Oil Rises On Renewed Iran Tension US futures whipsawed and crude oil spiked higher as tensions flared up again in the Middle East, taking the focus off a run of strong earnings by megacap tech companies. As of 8:00am ET, S&P and...
Zero Hedge
News Placeholder
Needham & Company LLC Raises Celcuity (NASDAQ:CELC) Price Target to $157.00
Needham & Company LLC increased their price target on Celcuity from $122.00 to $157.00 and gave the company a "buy" rating in a report on Monday...
MarketBeat
News Placeholder
Wall Street Believes Celcuity Could Become An Acquisition Target – Why This Analyst Raised Their Price Target By A Whopping 76%
H.C. Wainwright expressed optimism about the company’s prospects after Celcuity’s breast cancer therapy achieved its primary endpoint in a Phase 3 trial.
Stocktwits
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available